Actively Recruiting
Sentinel Node Mapping in High Risk Endometrial Cancer
Led by AC Camargo Cancer Center · Updated on 2024-07-30
178
Participants Needed
5
Research Sites
365 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study will evaluate the role of systematic lymphadenectomy after sentinel node (SLN) mapping in high risk endometrial cancer (high grade histologies or deep myometrial invasion). The participants will be randomized in a non-inferiority controlled trial in 2 groups: SLN mapping or SLN mapping followed by systematic lymphadenectomy.
CONDITIONS
Official Title
Sentinel Node Mapping in High Risk Endometrial Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- High grade histologies (endometrioid grade 3, serous, clear cell and carcinosarcoma)
- Endometrioid grades 1 or 2 with myometrial invasion of 6550%
- Endometrioid grades 1 or 2 with cervical invasion
- Clinically suitable to receive systematic lymphadenectomy
- Consent statement
You will not qualify if you...
- Previous hysterectomy in other institution
- Presence of extra-uterine disease (peritoneal, visceral or suspicious lymph node metastasis)
- Previous pelvic node dissection
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 5 locations
1
Hospital Erasto Gaertner
Curitiba, Paraná, Brazil
Actively Recruiting
2
Hospital do Cancer de Barretos
Barretos, São Paulo, Brazil
Actively Recruiting
3
AC Camargo Cancer Center
São Paulo, São Paulo, Brazil, 01509010
Actively Recruiting
4
Albert Einstein Hospital
São Paulo, São Paulo, Brazil
Actively Recruiting
5
Sao Camilo Oncologia
São Paulo, São Paulo, Brazil
Actively Recruiting
Research Team
B
Bruna Goncalves, RN, MSc
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here